3 Importantly, hair loss is not listed as a common side effect in the original semaglutide prescribing information, but pharmacovigilance data and post-marketing reports have made the association increasingly clear
Al-Aly explained that the use of GLP-1s has soared in the last couple years while multiple studies have captured their far-reaching benefits, but [we] realized that no one has comprehensively investigated the effectiveness and risks of GLP-1 receptor agonists across all possible health outcomes. In the study, Al-Aly and colleagues mapped out associations between GLP-1s and 175 possible health outcomes by comparing a cohort of people with diabetes who used the treatments (n = 215,970) with: those who used sulfonylureas (n = 159,465)
Nature 392 , 565568 (1998)
The guide also talks about how effective these medications can be
20 Jan What is Retatrutide
It also acquired a U.S.-based peptide facility based in California last year to expand its production of peptide treatments
